Microbiology for the Surgical Pathologist

  • Deborah E. Blue
  • Stephen D. Allen
Chapter

Abstract

Patients whose clinical illnesses are difficult to diagnose by clinical means and by microbiologic culture of easily obtainable specimens often undergo invasive procedures such as bronchoscopy, fine needle aspiration, or surgical biopsy procedures which can yield a definitive diagnosis. A summary of clinical presentation, macroscopic and microscopic features with special stains (morphologic findings in histologic sections yielding infectious disease diagnoses of specific infectious disease agents), differential diagnoses, and diagnostic techniques is presented for each organism that is discussed.

Keywords

Bacteria Aerobic Anaerobic Fungi Dimorphic Dermatophytes Yeasts Viruses Parasites Protozoa Cestodes Nematodes Microfilaria Trematodes 

Suggested Reading

  1. Akerlund T, Persson I, Unemo M, Noren T, Svenungsson B, Wullt M, Burman LG. Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1. J Clin Microbiol 2008;46:1530–1533.Google Scholar
  2. Benson RF, Tang PW, Fields BS. Evaluation of the Binax and Biotest urinary antigen kits for detection of Legionnaires’ disease due to multiple serogroups and species of Legionella. J Clin Microbiol 2000;38:2763–2765.Google Scholar
  3. Bisno AL, Brito MO, Collins CM. Molecular basis of group A streptococcal virulence. Lancet Infect Dis 2003;3:191–200.Google Scholar
  4. Bradsher RW, Jr. Pulmonary blastomycosis. Semin Respir Crit Care Med2008;29:174–181.Google Scholar
  5. Bryant AE, Bayer CR, Aldape MJ, Wallace RJ, Titball RW, Stevens DL. Clostridium perfringens phospholipase C-induced platelet/leukocyte interactions impede neutrophil diapedesis. J Med Microbiol 2006;55:495–504.Google Scholar
  6. Bryant AE, Chen RY, Nagata Y, Wang Y, Lee CH, Finegold S, Guth PH, Stevens DL. Clostridial gas gangrene. I. Cellular and molecular mechanisms of microvascular dysfunction induced by exotoxins of Clostridium perfringens. J Infect Dis 2000;182:799–807.Google Scholar
  7. Bryant AE, Chen RY, Nagata Y, Wang Y, Lee CH, Finegold S, Guth PH, Stevens DL. Clostridial gas gangrene. II. Phospholipase C-induced activation of platelet gpIIbIIIa mediates vascular occlusion and myonecrosis in Clostridium perfringens gas gangrene. J Infect Dis 2000;182:808–815.Google Scholar
  8. Chandler FW, Watts JC, (eds.). Pathologic diagnosis of fungal infections. ASCP Press, Chicago, 1987.Google Scholar
  9. Connor DH, (eds.). Pathology of infectious diseases. Appleton & Lange, Stamford, Conn., 1997.Google Scholar
  10. Cunningham MW. Pathogenesis of group A streptococcal infections and their sequelae. Adv Exp Med Biol 2008;609:29–42.Google Scholar
  11. Cutaneous leishmaniasis in U.S. military personnel--Southwest/Central Asia, 2002–2004. MMWR Morb Mortal Wkly Rep 2004;53:264–265.Google Scholar
  12. Damjanov I, Linder J, Anderson WAD, (eds.). Anderson’s pathology. Mosby, St. Louis, 1996.Google Scholar
  13. Daum RS. Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med 2007;357:380–390.Google Scholar
  14. Driscoll JA, Brody SL, Kollef MH. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 2007;67:351–368.Google Scholar
  15. Dutra WO, Gollob KJ. Current concepts in immunoregulation and pathology of human Chagas disease. Curr Opin Infect Dis 2008;21:287–292.Google Scholar
  16. Eisenman HC, Casadevall A, McClelland EE. New insights on the pathogenesis of invasive Cryptococcus neoformans infection. Curr Infect Dis Rep 2007;9:457–464.Google Scholar
  17. Fields BS, Benson RF, Besser RE. Legionella and Legionnaires’ disease: 25 years of investigation. Clin Microbiol Rev 2002;15:506–526.Google Scholar
  18. Filler SG. Candida-host cell receptor-ligand interactions. Curr Opin Microbiol 2006;9:333–339.Google Scholar
  19. Garcia LS, (eds.). Diagnostic medical parasitology. ASM Press, Washington, D.C., 2007.Google Scholar
  20. Greenberg RN, Scott LJ, Vaughn HH, Ribes JA. Zygomycosis (mucormycosis): emerging clinical importance and new treatments. Curr Opin Infect Dis 2004;17:517–525.Google Scholar
  21. Guarner J, Jernigan JA, Shieh WJ, Tatti K, Flannagan LM, Stephens DS, Popovic T, Ashford DA, Perkins BA, Zaki SR. Pathology and pathogenesis of bioterrorism-related inhalational anthrax. Am J Pathol 2003;163:701–709.Google Scholar
  22. Guilherme L, Kalil J, Cunningham M. Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity 2006;39:31–39.Google Scholar
  23. Gupta A, Polyak CS, Bishop RD, Sobel J, Mintz ED. Laboratory-confirmed shigellosis in the United States, 1989–2002: epidemiologic trends and patterns. Clin Infect Dis 2004;38:1372–1377.Google Scholar
  24. Hadfield TL, McEvoy P, Polotsky Y, Tzinserling VA, Yakovlev AA. The pathology of diphtheria. J Infect Dis 2000;181 Suppl 1:S116–120.Google Scholar
  25. Hage CA, Davis TE, Egan L, Parker M, Fuller D, Lemonte AM, Durkin M, Connelly P, Joseph Wheat L, Blue-Hnidy D, Knox KS. Diagnosis of pulmonary histoplasmosis and blastomycosis by detection of antigen in bronchoalveolar lavage fluid using an improved second-generation enzyme-linked immunoassay. Respir Med 2007;101:43–47.Google Scholar
  26. Hage CA, Wheat LJ, Loyd J, Allen SD, Blue D, Knox KS. Pulmonary histoplasmosis. Semin Respir Crit Care Med 2008;29:151–165.Google Scholar
  27. Haldar K, Murphy SC, Milner DA, Taylor TE. Malaria: mechanisms of erythrocytic infection and pathological correlates of severe disease. Annu Rev Pathol 2007;2:217–249.Google Scholar
  28. Hawkes M, Kain KC. Advances in malaria diagnosis. Expert Rev Anti Infect Ther 2007;5:485–495.Google Scholar
  29. Hoppa E, Bachur R. Lyme disease update. Curr Opin Pediatr 2007;19:275–280.Google Scholar
  30. Hotez PJ, Brooker S, Bethony JM, Bottazzi ME, Loukas A, Xiao S. Hookworm infection. N Engl J Med 2004;351:799–807.Google Scholar
  31. Janka J, O’Grady NP. Clostridium difficile infection: current perspectives. Curr Opin Crit Care 2009;15:149–153.Google Scholar
  32. Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, Tapper M, Fisk TL, Zaki S, Popovic T, Meyer RF, Quinn CP, Harper SA, Fridkin SK, Sejvar JJ, Shepard CW, McConnell M, Guarner J, Shieh WJ, Malecki JM, Gerberding JL, Hughes JM, Perkins BA. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001;7:933–944.Google Scholar
  33. Johnson DR, Wotton JT, Shet A, Kaplan EL. A comparison of group A streptococci from invasive and uncomplicated infections: are virulent clones responsible for serious streptococcal infections? J Infect Dis 2002;185:1586–1595.Google Scholar
  34. Jones JL, Dargelas V, Roberts J, Press C, Remington JS, Montoya JG. Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis 2009;49:878–884.Google Scholar
  35. Kauffman HF. Immunopathogenesis of allergic bronchopulmonary aspergillosis and airway remodeling. Front Biosci 2003;8:e190–196.Google Scholar
  36. Kaur R, Domergue R, Zupancic ML, Cormack BP. A yeast by any other name: Candida glabrata and its interaction with the host. Curr Opin Microbiol 2005;8:378–384.Google Scholar
  37. Keiser PB, Nutman TB. Strongyloides stercoralis in the Immuno­compromised Population. Clin Microbiol Rev 2004;17:208–217.Google Scholar
  38. King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM. Emergence of community-acquired methicillin-resistant Staphy­lococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 2006;144:309–317.Google Scholar
  39. Krause PJ. Babesiosis diagnosis and treatment. Vector Borne Zoonotic Dis 2003;3:45–51.Google Scholar
  40. Larone DH, (eds.). Medically important fungi: a guide to identification. ASM Press, Washington, D.C., 2002.Google Scholar
  41. Latge JP, Calderone R. Host-microbe interactions: fungi invasive human fungal opportunistic infections. Curr Opin Microbiol 2002;5:355–358.Google Scholar
  42. Layton AN, Galyov EE. Salmonella-induced enteritis: molecular pathogenesis and therapeutic implications. Expert Rev Mol Med 2007;9:1–17.Google Scholar
  43. Mandell GL, Douglas RG, Bennett JE, Dolin R, (eds.). Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Elsevier Churchill Livingstone, Philadelphia, 2005.Google Scholar
  44. Mooi FR, van Loo IH, van Gent M, He Q, Bart MJ, Heuvelman KJ, de Greeff SC, Diavatopoulos D, Teunis P, Nagelkerke N, Mertsola J. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 2009;15:1206–1213.Google Scholar
  45. Murray PR, Baron EJ, (eds.). Manual of clinical microbiology. ASM Press, Washington, D.C., 2007.Google Scholar
  46. Murray PR, Rosenthal KS, Pfaller MA, (eds.). Medical microbiology. Mosby/Elsevier, Philadelphia, 2009.Google Scholar
  47. Nett J, Andes D. Candida albicans biofilm development, modeling a host-pathogen interaction. Curr Opin Microbiol 2006;9:340–345.Google Scholar
  48. Newman LM, Moran JS, Workowski KA. Update on the management of gonorrhea in adults in the United States. Clin Infect Dis 2007;44 Suppl 3:S84–101.Google Scholar
  49. Newsome AL, Scott TM, Benson RF, Fields BS. Isolation of an amoeba naturally harboring a distinctive Legionella species. Appl Environ Microbiol 1998;64:1688–1693.Google Scholar
  50. Nigrovic LE, Wingerter SL. Tularemia. Infect Dis Clin North Am 2008;22:489–504, ix.Google Scholar
  51. Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med 2005;352:2325–2336.Google Scholar
  52. Powers CN. Diagnosis of infectious diseases: a cytopathologist’s perspective. Clin Microbiol Rev 1998;11:341–365.Google Scholar
  53. Prentice MB, Rahalison L. Plague. Lancet 2007;369:1196–1207.Google Scholar
  54. Procop GW, Wilson M. Infectious disease pathology. Clin Infect Dis 2001;32:1589–1601.Google Scholar
  55. Rocha A, de Meneses AC, da Silva AM, Ferreira MS, Nishioka SA, Burgarelli MK, Almeida E, Turcato Junior G, Metze K, Lopes ER. Pathology of patients with Chagas’ disease and acquired immunodeficiency syndrome. Am J Trop Med Hyg 1994;50:261–268.PubMedGoogle Scholar
  56. Romani L. Immunity to fungal infections. Nat Rev Immunol 2004;4:1–23.PubMedCrossRefGoogle Scholar
  57. Ross AG, Bartley PB, Sleigh AC, Olds GR, Li Y, Williams GM, McManus DP. Schistosomiasis. N Engl J Med 2002;346:1212–1220.PubMedCrossRefGoogle Scholar
  58. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009;7:526–536.PubMedCrossRefGoogle Scholar
  59. Sansonetti PJ. Microbes and microbial toxins: paradigms for microbial-mucosal interactions III. Shigellosis: from symptoms to molecular pathogenesis. Am J Physiol Gastrointest Liver Physiol 2001;280:G319–323.Google Scholar
  60. Seveau S, Pizarro-Cerda J, Cossart P. Molecular mechanisms exploited by Listeria monocytogenes during host cell invasion. Microbes Infect 2007;9:1167–1175.PubMedCrossRefGoogle Scholar
  61. Seybold U, Kourbatova EV, Johnson JG, Halvosa SJ, Wang YF, King MD, Ray SM, Blumberg HM. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006;42:647–656.PubMedCrossRefGoogle Scholar
  62. Shrivastava R, Miller JF. Virulence factor secretion and translocation by Bordetella species. Curr Opin Microbiol 2009;12:88–93.PubMedCrossRefGoogle Scholar
  63. Stephens DS. Conquering the meningococcus. FEMS Microbiol Rev 2007;31:3–14.PubMedCrossRefGoogle Scholar
  64. Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 2007;369:2196–2210.PubMedCrossRefGoogle Scholar
  65. Sturm A, Amino R, van de Sand C, Regen T, Retzlaff S, Rennenberg A, Krueger A, Pollok JM, Menard R, Heussler VT. Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science 2006;313:1287–1290.PubMedCrossRefGoogle Scholar
  66. Swartz MN. Recognition and management of anthrax--an update. N Engl J Med 2001;345:1621–1626.CrossRefGoogle Scholar
  67. Torres HA, Reddy BT, Raad, II, Tarrand J, Bodey GP, Hanna HA, Rolston KV, Kontoyiannis DP. Nocardiosis in cancer patients. Medicine (Baltimore) 2002;81:388–397.Google Scholar
  68. Weinberg GA. Laboratory diagnosis of ehrlichiosis and babesiosis. Pediatr Infect Dis J 2001;20:435–437.PubMedCrossRefGoogle Scholar
  69. White AC, Jr. Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management. Annu Rev Med 2000;51:187–206.CrossRefGoogle Scholar
  70. Whiteway M, Oberholzer U. Candida morphogenesis and host-pathogen interactions. Curr Opin Microbiol 2004;7:350–357.PubMedCrossRefGoogle Scholar
  71. Winn WC, Koneman EW, (eds.). Koneman’s color atlas and textbook of diagnostic microbiology. Lippincott Williams & Wilkins, Philadelphia, 2006.Google Scholar
  72. Young JA, Collier RJ. Anthrax toxin: receptor binding, internalization, pore formation, and translocation. Annu Rev Biochem 2007;76:243–265.PubMedCrossRefGoogle Scholar
  73. Zaharik ML, Gruenheid S, Perrin AJ, Finlay BB. Delivery of dangerous goods: type III secretion in enteric pathogens. Int J Med Microbiol 2002;291:593–603.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Deborah E. Blue
    • 1
  • Stephen D. Allen
    • 2
  1. 1.Division of Translational Science and Molecular Medicine, Division of Human Pathology, Department of PhysiologyMichigan State University College of Human MedicineGrand RapidsUSA
  2. 2.Division of Clinical Microbiology, Department of Pathology and Laboratory MedicineIndiana University School of MedicineIndianapolisUSA

Personalised recommendations